01 September 2005
Chemotherapeutics targeting immune activation by staphylococcal superantigens.
Teresa KrakauerMed Sci Monit 2005; 11(9): RA290-295 :: ID: 428464
Abstract
Staphylococcal enterotoxin B (SEB) and related superantigenic toxins arepotent activators of the immune system and cause a variety of diseases in humans, ranging from food poisoningto toxic shock. These toxins bind to both MHC class II molecules and specific Vb regions of T cell receptors(TCR), resulting in the activation of both monocytes/macrophages and T lymphocytes. The interactionsof these toxins with host cells lead to excessive production of proinflammatory cytokines and T cellproliferation, causing clinical symptoms that include fever, hypotension and shock. Different domainsof SEB contributing to MHC class II or TCR interactions have been mapped and defined by mutagenesis,crystallography and other biochemical techniques. This review summarizes the in vitro and in vivo effectsof staphylococcal superantigens, and the therapeutic agents to mitigate their toxic effects. Potentialtargets to prevent the toxic effects of bacterial superantigens include blocking the interaction of SEswith MHC or TCR, or other costimulatory molecules; inhibition of signal transduction pathways used bythese superantigens; inhibition of cytokine and chemokine production; and inhibition of the downstreamsignaling pathways used by proinflammatory cytokines and chemokines. Early blockade of these targetsproves to be useful in vitro and in vivo testing of therapeutics against SEB-induced toxic shock willalso be reviewed.
Keywords: Enterotoxins - toxicity, Immunosuppressive Agents - therapeutic use, Lymphocyte Activation - drug effects, Shock, Septic - immunology, Superantigens - toxicity, T-Lymphocytes - immunology
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952